In its most recent report, Nanalysis Scientific Corp. disclosed quarterly revenue of $10.7 million and adjusted EBITDA of $1.2 million. The full-year revenue amounted to $40.1 million with adjusted EBITDA reaching $903 thousand. Based in Calgary, AB, the company, known for its expertise in portable NMR technology, shared this financial update on April 8, 2026. Trading under TSXV: NSCI and FRA: 1N1, Nanalysis Scientific Corp. continues to demonstrate its strong performance in the market.